By Frank Prenesti
Date: Monday 21 Jul 2025
(Sharecast News) - US healthcare company Johnson & Johnson raised on Wednesday annual earnings and sales guidance on the back of strong sales and foreign exchange tailwinds, sending shares in the firm up 5.5%.
Johnson & Johnson agrees to pay £13bn for Switze... | 28-Apr-2011 | The Independent |
S&N DRIFTS AS BID HOPES SLIP | 19-Apr-2011 | Express & Star |
J&J asks judge to dismiss kickback case | 08-Oct-2010 | Wall Street Journal |
Genzyme Again Rejects Sanofi’s Bid | 08-Oct-2010 | New York Times |
Johnson & Johnson buying vaccine maker Crucell | 07-Oct-2010 | USA Today |
Currency | US Dollars |
Share Price | $ 175.70 |
Change Today | $ 1.28 |
% Change | 0.73 % |
52 Week High | $175.72 |
52 Week Low | $142.06 |
Volume | 5,171,405 |
Shares Issued | 2,406.92m |
Market Cap | $422,884m |
Beta | 0.06 |
RiskGrade | 87 |
Strong Buy | 6 |
Buy | 5 |
Neutral | 14 |
Sell | 0 |
Strong Sell | 0 |
Total | 25 |
Time | Volume / Share Price |
15:20 | 100 @ $175.70 |
15:20 | 100 @ $175.70 |
15:20 | 100 @ $175.70 |
15:20 | 361 @ $175.70 |
15:20 | 100 @ $175.71 |
You are here: research